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Abstract 
This study investigates the retention mechanisms of three pharmaceuticals  sulfamethoxazole, 
carbamazepine, and ibuprofen  by nanofiltration (NF) membranes.  Laboratory-scale experiments 
were carried out with two well-characterized NF membranes, with the goal of relating 
pharmaceutical retention behavior to membrane characteristics, physicochemical properties of the 
pharmaceutical molecules, and solution chemistry.  Results show that retention of pharmaceuticals 
by a tight NF membrane is dominated by steric (size) exclusion, whereas both electrostatic 
repulsion and steric exclusion govern the retention of ionizable pharmaceuticals by a loose NF 
membrane.  In the latter case, speciation of pharmaceuticals may lead to a dramatic change in 
retention as a function of pH, with much greater retention observed for ionized, negatively charged 
pharmaceuticals.  For uncharged pharmaceutical species, intrinsic physicochemical properties of the 
pharmaceutical molecules can substantially affect their retention.  In its neutral form, ibuprofen 
adsorbs considerably to the membrane because of its relatively high hydrophobicity.  Similarly, 
polarity (represented by the dipole moment) can influence the separation of molecules that are 
cylindrical in shape as they can be directed to approach the membrane pores head on due to 
attractive interaction between the molecule polar centers and fix charged groups on the membrane 
surface.  This phenomenon is probably inherent for high dipole moment organic compounds and the 
governing retention mechanism remains steric in nature. 
Introduction 
Pharmaceuticals have been of tremendous benefit to our society for treatment and prevention of 
illnesses as well as promoting growth and good health.  Not surprisingly, thousands of 
pharmaceuticals are being produced and used at vast quantities.  This has, however, prompted great 
concern as solid evidence of widespread occurrence of pharmaceutically active compounds 
(PhACs) in the aquatic environment at trace levels is starting to emerge.  Since they are often not 
fully assimilated by humans and animals during treatment, these pharmaceuticals are continuously 
released to the environment mostly via domestic wastewater effluent in the original or partly 
metabolized forms.  
Currently, most wastewater treatment plants (WWTPs) are not designed to eliminate trace 
organic contaminants.  The capacity of WWTPs to remove PhACs depends essentially on the 
biological treatment stage, where PhACs are removed predominantly by sorption to suspended 
solids and by biological degradation.  Removal of several hydrophobic compounds has been 
reported to be positively correlated to the sludge retention time (SRT), with an SRT of at least 10 
days being needed to achieve effective removal (1, 2).  However, many WWTPs in the United 
States and Europe are not designed with a long enough SRT to satisfy this requirement (2).  The 
low influent concentration of PhACs and seasonal temperature changes can further complicate the 
problem (1).  Some pharmaceuticals such as carbamazepine are highly persistent and have been 
shown to be inert to the biological treatment process (1, 3).  In fact, carbamazepine has even been 
suggested as a possible anthropogenic marker in the aquatic environment (3).  Consequently, 
removal efficiencies of PhACs by WWTPs vary greatly, with the overall removal generally quite 
low.  Not surprisingly, PhACs are ubiquitous in most secondary treated effluents and receiving 
freshwater bodies.  
In studies carried out in many countries, including Australia, Austria, Brazil, Canada, 
Croatia, England, Germany, Greece, Italy, Spain, Switzerland, the Netherlands, and the U.S., more 
than 80 pharmaceuticals and their metabolites have been detected in aquatic environments at 
concentrations in the microgram per liter range or lower (4-10).  Because pharmaceuticals are 
designed to be biologically active, they have the potential to affect a large variety of non-target 
organisms for a wide range of physiological consequences.  For example, the potential for induction 
(11, 12) or proliferation of antibiotic resistance (11, 13, 14) due to low concentrations of antibiotic 
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agents in the environment is of increasing concern to scientists.  Although potential chronic effects 
of PhACs at trace levels remain largely unknown, it is unanimously accepted that preventing such 
PhACs from entering the aquatic environment is essential (2), and a precautionary approach is 
required.  Removal of PhACs from secondary effluents prior to water reuse is also of paramount 
importance, as augmentation of water supply by wastewater reuse has recently gathered substantial 
momentum (15-17). 
Nanofiltration (NF) is an important technology for water recycling.  Complete or near 
complete removal of a wide range of contaminants in secondary effluents can be achieved with NF 
membranes (18-21).  However, such premise should not be generalized to all trace contaminants.  
As illustrated in our previous study, natural steroid hormones can adsorb (or partition) onto the 
membrane and subsequently diffuse through the membrane polymer (22).  This process may result 
in trace contaminant removals much lower than those predicted based on a steric (size) exclusion 
mechanism.  Furthermore, retention of trace organics by NF membranes highly depends on the 
compound physicochemical properties, which can be influenced by solution chemistry, particularly 
by the solution pH.  To date, the intricate relationship between the physicochemical properties of 
trace organics, solution chemistry, and membrane retention behavior remains poorly understood.  
Delineation of the fundamental mechanisms governing trace organic contaminant removal by NF 
membranes will markedly enhance the use of NF membrane technology in water reuse applications.  
The objective of this study is to examine the removal mechanisms of three pharmaceuticals 
 sulfamethoxazole, carbamazepine, and ibuprofen  by two thin-film composite NF membranes.  
These compounds represent different pharmaceutical groups with quite distinct physicochemical 
properties.  Experiments were carried out with two NF membranes having well-characterized pore 
sizes.  Retention behavior was related to the physicochemical properties of the pharmaceuticals and 
the membranes as well as the solution chemistry.  On the basis of these results, mechanisms of 
pharmaceutical retention by NF membranes are elucidated and discussed.   
Materials and Methods 
NF Membranes.  Two NF membranes, denoted NF-270 and NF-90 by the manufacturer (FilmTec 
Corp., Minneapolis, MN), were used in this investigation.  These are polyamide thin-film composite 
membranes.  The membranes were received as flat sheet samples.  They were gently washed with 
deionized water (DI) to remove any preservatives and were stored in DI water at 4 °C.   
Membrane Zeta Potential.  Membrane surface steaming potential was measured using a 
commercial streaming potential analyzer (BI-EKA, Brookhaven Instruments Corp., Holtsville, NY).  
Details on the instrument, measurement procedure, and zeta potential calculation from the measured 
streaming potential are described elsewhere (23, 24).  Streaming potential measurements were 
conducted in a background electrolyte solution containing 20 mM NaCl and 1 mM NaHCO3 over 
the pH range of 2.5 to 11.0. 
Pharmaceuticals.  Three pharmaceuticals, namely, sulfamethoxazole, carbamazepine, and 
ibuprofen were selected for this study (Figure 1).  The compounds were purchased from Sigma-
Aldrich (Saint Louis, MO) and are reported to be of 99 % purity or higher.  These pharmaceuticals 
represent three important drug categories.  Sulfamethoxazole is an important member of the 
sulfonamide antibacterials and is probably the most frequently used antibiotic; carbamazepine is 
one of the most widely used anti-epileptic drugs; and ibuprofen is a common anti-inflammatory 
agent.  As seen in Figure 1, the pharmaceuticals have quite distinctive functional groups.  Stock 
solutions (1 g/L) were prepared in pure methanol for all three pharmaceuticals.  The stock solutions 
were stored at < 4 oC and were used within 1 month. 
[FIGURE 1] 
Analytical Methods.  A Shimadzu HPLC system equipped with a Supelco Drug Discovery 
C-18 column (with diameter, length, and pore size of 4.6 mm, 250 mm, and 5 µm, respectively) and 
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a UV detector was used to analyze pharmaceutical concentration in the feed and permeate samples.  
Detection wavelengths for sulfamethoxazole and carbamazepine were set at 280 nm, and for 
ibuprofen at 225 nm.  The mobile phase for gradient elution was deionized water (buffered with 
0.025 M KH2PO4) and acetonitrile (ACN), delivered at a constant flow rate of 1 mL/min.  A 
gradient program for the mobile phase was set in accordance with the chromatographic behavior of 
the respective analytes.  The total run time for each HPLC analysis was 25 min.  A sample injection 
volume of 50 µL was used, and a typical quantification limit for all analytes under these conditions 
was approximately 20 µg/L.  Standard curves yielded coefficients of determination (R2) greater than 
0.98 within the range of experimental concentrations in all cases.  Analysis was carried out 
immediately following the nanofiltration experiments.  
Laboratory-Scale NF Test Unit.  A laboratory-scale NF/RO membrane filtration test unit 
was used.  The unit utilizes a Dayton capacitor start motor (Dayton Electronic Manufacturing Co., 
Chicago, IL) coupled with a Hydra-Cell pump (Wanner Engineering Inc., Minneapolis, MN) 
capable of providing pressures up to 69 bar and a cross-flow of 4.2 liters per minute.  Temperature 
of the feed reservoir was controlled using a chiller/heater (Neslab RTE 7).  A seawater grade 
stainless steel rectangular cross flow cell with an effective membrane area of 40 cm2 and a channel 
height of 2 mm was used in the test unit.  Permeate flow rate was measured by a digital flow meter 
connected to a PC and the cross flow rate was monitored with a rotameter.  
Filtration Protocol.  Prior to each experiment, the membrane was stabilized at 12 bar using 
DI water for at least 16 hours until there was no variation in permeate flux.  The feed reservoir 
temperature was kept constant at 20±0.1 oC throughout the experiment.  Both permeate and 
retentate were recirculated back to the feed reservoir.  In all filtration experiments, background 
electrolyte solution contained 20 mM NaCl and 1 mM NaHCO3, and, unless otherwise stated, the 
pH was kept at 8.  
Prior to experimenting with pharmaceuticals, 7 liters of DI water was introduced to the feed 
reservoir.  The cross flow velocity and permeate flux were adjusted to 30.4 cm/s and 15 µm/s (54 
Lm−2h−1), respectively.  To achieve this permeate flux, the transmembrane pressures were set to 
approximately 4.5 and 6 bar for the NF-270 and the NF-90 membranes, respectively.  
Pharmaceuticals were then spiked into the feed reservoir to make up a concentration of 500 µg/L.  
Approximately 1.5 mL of feed and permeate samples were taken for analysis at specified time 
intervals.  For experiments with variable pH, the solution was adjusted to pH 10.5 by the addition of 
NaOH.  The pH was then incrementally dropped to 3.5 by the addition of HCl, and the system was 
equilibrated for 1 hour prior to sample collection for analysis at each pH value. 
Results and Discussion 
NF Membrane Characteristics.  Membrane surface chemical characteristics are determined by a 
very thin polyamide layer, which makes up the active layer of the two NF membranes used in this 
investigation (25). This polyamide layer contains both carboxylic and amine functional groups that 
can ionize in an aqueous solution (23, 26).  Consequently, the membrane zeta potential varies as a 
function of pH (Figure 2).  The NF-270 membrane has an isoelectric point at approximately pH 3.5 
and that of the NF-90 membrane is approximately at pH 4.  At pH below the isoelectric point, the 
membranes have a slightly positive charge.  Above the isoelectric point, the membranes are 
negatively charged, with the zeta potential becoming more negative as the pH increases.  Since 
separation of ionic species by nanofiltration membranes is governed by both size (steric) exclusion 
and electrostatic interaction (26-29), this amphoteric characteristic of the membrane surface has 
important implications with regard to the solute retention mechanisms of the membranes. 
[FIGURE 2] 
The average pore radii of the membranes have been characterized in our previous study by 
challenging the membranes with a series of inert organic tracers of various molecular weights and 
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applying a pore transport model (22).  It was concluded that the NF-270 is a “loose” NF membrane 
with an average pore radius of 0.42 nm, whilst the NF-90 is a “tight” NF membrane with an average 
pore radius of 0.34 nm.  The difference in pore size and the amphoteric nature of the membrane 
surface are clearly reflected in the salt (conductivity) retention behavior of these two membranes as 
described in Figure 3.  As the pH is decreased, the membrane becomes less negatively charged 
(Figure 2).  Consequently, electrostatic (charge) exclusion of ionic species by the membrane 
diminishes and completely vanishes at the isoelectric point.  This results in a dramatic drop in salt 
(conductivity) retention by the loose NF-270 membrane as the pH decreases to 4, where a minimum 
retention is observed due to an absence of electrostatic repulsion at the isoelectric point (26).  While 
both steric and electrostatic interactions are responsible for the separation of ionic species by the 
loose NF membrane, it is evident that salt retention by the tight NF-90 membrane is predominantly 
governed by steric exclusion.  Conductivity retention by the NF-90 is substantially higher than that 
by the NF-270, and only a relatively small decrease in retention can be observed when the pH is 
reduced. 
[FIGURE 3] 
Physicochemical Properties of Pharmaceuticals.  The biological and chemical activity of 
pharmaceuticals is strongly influenced by their functional groups.  The chemical speciation of 
pharmaceuticals is governed by solution pH and the compound dissociation constants or the pKa 
values (30).  Because of differences in charge and physicochemical properties of the various species 
of a given pharmaceutical, their NF separation behavior may differ significantly. 
The three pharmaceuticals selected for this study are markedly different in their 
physicochemical properties, although they all have similar molecular weights in the range between 
206 and 253 g/mol (Table 1).  Of a particular note is the very high dipole moment of both 
sulfamethoxazole and carbamazepine.  These are permanent dipole moments, which are calculated 
using the HyperChem commercial software (31), and do not include the induced dipole moment 
resulting from the electrical field of the membrane surface.  As we show later in the paper, the 
compound dipole moment can play an important role in retention by the NF membranes by 
affecting the molecule orientation as it approaches the membrane pores. 
[TABLE 1] 
Since carbamazepine is a base with a pKa value of 2.3, the compound is uncharged at all 
conditions typical of natural or waste waters.  In contrast, speciation of both ibuprofen and 
sulfamethoxazole is expected in the pH range commonly encountered in nanofiltration processes.  
Sulfamethoxazole contains two functional moieties at both sides of the sulfonamide linkage (–NH–
S(O2)–).  Consequently, sulfamethoxazole exhibits two dissociation constants, one involving the 
protonation of the primary aromatic amine –NH2 and the other corresponding to the deprotonation 
of the sulfoamide –NH as illustrated in Figure 4.  This figure also shows the speciation of 
sulfamethoxazole over the entire pH range.  At pH above 5.7, sulfamethoxazole exists 
predominantly as an anionic species, between pH 1.7 and pH 5.7 the compound is uncharged, while 
at pH below 1.7 it is positively charged.        
[FIGURE 4] 
Solution pH can affect not only charge but also other physicochemical properties of the 
pharmaceuticals, particularly hydrophobicity and solubility (32-34).  Significant variation of both 
hydrophobicity and solubility of several pharmaceuticals as a function of the solution pH has been 
reported (33, 34).  Values for Log Kow and solubility in water of the three pharmaceuticals, 
summarized in Table 1, were obtained from the literature.  Although the corresponding pH is 
unknown, it is assumed that they represent characteristics of the compounds in their neutral form. 
Pharmaceutical Retention by NF Membranes: General Behavior.  Figure 5 presents the 
concentration of sulfamethoxazole, ibuprofen, and carbamazepine in both permeate and feed as a 
6 
function of time during filtration with the NF-270 and NF-90 membranes at pH 8.0.  While 
carbamazepine is neutrally charged at the pH of the experiment, the other two compounds are 
negatively charged at this pH.  In contrast to nanofiltration of hydrophobic trace organics, such as 
steroid hormones and hormone mimicking compounds which adsorb quite strongly to the 
membranes (22), these pharmaceuticals do not adsorb to the membranes at this experimental 
condition as evidenced from their constant feed concentrations for the duration of the runs.  
Sulfamethoxazole and carbamazepine have a low affinity to the membrane polymer, indicated by 
their relatively low log Kow value (Table 1).  The high log Kow of ibuprofen listed in Table 1 is for 
the uncharged species which are prevalent below the pKa, not for the negatively charged 
deprotonated species at the pH of these experiments.   
[FIGURE 5] 
As the experiments progress, both permeate and feed concentrations appear stable, 
corresponding to a constant retention over time.  The contribution of electrostatic interaction to 
retention is evident in the nanofiltration of the negatively charged sulfamethoxazole and ibuprofen 
at the solution conditions (pH 8).  No sulfamethoxazole or ibuprofen are detected in the permeate 
following filtration by the tight NF-90 membrane, while the looser NF-270 membrane also achieves 
a very high, but not complete removal of both compounds (Figures 5a-5d).  The retention of these 
pharmaceuticals is higher than that of carbamazepine (Figures 5e and 5f), which is retained solely 
via steric interaction because it is neutrally charged above pH 2.3 (Table 1).  Overall, the retention 
of the three model pharmaceuticals is quite high, and is attributed to the size and charge of the 
pharmaceutical species at this particular experimental condition (pH 8).   
Pharmaceutical Retention by NF Membranes: Role of Solution pH.  Retention of 
pharmaceuticals by NF membranes is determined by the coupled influence of the compound 
speciation behavior, the membrane pore size and surface charge (represented by the zeta potential), 
and the compound physicochemical properties (i.e., size, steric characteristics, log Kow, and dipole 
moment).  Figure 6 describes the retention of the three pharmaceuticals by the NF-90 and NF-270 
membranes over the pH range 3.5 – 10.5.  Over this wide pH range, the pharmaceutical compounds 
and the membrane display a wide variation in speciation (or charge) and physicochemical 
properties, thus allowing a more systematic investigation of the retention mechanisms involved.  
Complete or near complete retention of all three pharmaceuticals by the tight NF-90 membrane is 
observed over the entire pH range, despite the marked effect of pH on the charge of both the 
pharmaceutical compounds and the membrane surface.  The retention behavior of the loose NF-270 
membrane is, however, quite different.  The corresponding retention behavior and associated 
mechanisms for each of the three pharmaceuticals are discussed below. 
[FIGURE 6] 
(a) Retention of Sulfamethoxazole.  Solution pH affects markedly sulfamethoxazole 
retention by the loose NF-270 membrane.  Because sulfamethoxazole transforms from a negatively 
charged to a neutral species as the solution pH decreases from 10.5 to 3.5, the retention by the NF-
270 membrane declines dramatically from a value as high as 100% to only 25% at low pH.  This 
decline in retention can also be attributed to a decrease in the membrane zeta potential as the 
solution pH decreases (Figure 2).  In contrast, only a subtle but nevertheless discernible drop in 
retention by the tight NF-90 membrane can be observed as the solution pH decreases to below pH 6 
(i.e., retention drops from 100% to 98%).  This result indicates that pharmaceutical retention by this 
tight NF membrane is predominantly governed by steric interaction.  On the other hand, both 
electrostatic repulsion and steric interaction are responsible for the retention of charged 
pharmaceuticals by the loose NF membrane.  
Although the degree of sulfamethoxazole retention is markedly different for the tight NF-90 
and the loose NF-270 membranes, retention behavior as a function of pH for both membranes 
follows a sigmoidal shape, resembling the compound speciation curve.  It is interesting to note that 
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the inflection point deviates slightly from the pKa value (5.7) of sulfamethoxazole.  A similar 
observation can also be inferred from the data reported by Bellona and Drewes (35).  This behavior 
can partly be attributed to the negative proton retention often observed in an acidic solution (26, 
36).  Because the H+ ion is more mobile or permeable than the other monovalent cations in solution 
(i.e., Na+), negative retention of the more permeable ion is possible when the ratio of the more 
permeable ion to the less permeable ion is low (27).  Negative proton retention of up to 400% has 
been reported for the loose NF-45 membrane at pH 4.5 (36).  Due to the passage of protons through 
the membrane pores, local pH in the membrane pore would be lower than that at the bulk solution, 
which to some extent could explain the deviation between the inflection point and the pKa value of 
sulfamethoxazole as seen in Figure 6a.  Proton passage is more substantial for the loose NF-270 
membrane where Donnan exclusion plays a more significant role (36).  This is consistent with the 
fact that the deviation from the pKa value is more significant for the loose NF-270 membrane, while 
it is almost negligible for the tight NF-90 membrane (Figure 6a).  Negative proton retention by the 
NF-90 and NF-270 membranes has been confirmed by measuring the pH of the feed and permeate 
samples.  However, the difference was found to be relatively small, in the range of 0.2 – 0.3 pH 
units at pH 4.  Although it is possible that, due to the small pore volume, pH at the membrane pore 
can be significantly less than that of the bulk solution where the pH measurement takes place, it is 
probable that other factors may also contribute to the divergence of the inflection point from the 
pKa. 
(b) Retention of Carbamazepine.  Carbamazepine (pKa = 2.45, Table 1) is neutrally 
charged at the pH range of the experiment.  Its retention by both the NF-90 and the NF-270 
membranes is relatively constant, because the retention is solely governed by steric (size) exclusion 
(Figure 6b) in the absence of charged functional groups.  In the absence of electrostatic (charge) 
repulsion, the compound physicochemical properties can influence the retention behavior.  It is 
striking that the retention of the neutral species of sulfamethoxazole is significantly lower than that 
of carbamazepine (compare Figures 6a and 6b), despite the higher molecular weight of 
sulfamethoxazole compared to carbamazepine (Table 1).  This phenomenon can be explained 
following the suggestion of Bruggen et al. (37) that organic molecules with high dipole moments 
(above 3 Debye) can show lower retention than molecules with approximately the same molecular 
weight but with a lower dipole moment.  Because of the attraction between polar moieties of the 
molecule and the membrane fixed charged groups, the molecule is directed towards the membrane 
pore in an orientated instead of a random fashion.  This results in a statistical propensity of the 
transported molecules to approach the membrane pores with a preferential orientation, in such a 
way that the side of the dipole which induces attraction with the fixed negative charge of the 
membrane pore is closer to the pore entrance.  The effect is apparent when comparing the three-
dimensional models of sulfamethoxazole and carbamazepine (Figure 7).  The sulfamethoxazole 
molecule is long and cylindrical in shape with its dipole moment (5.4 Debye) acting along the main 
axis.  By contrast, carbamazepine has a lower dipole moment (3.6 Debye) and is more bulky in 
shape.     
[FIGURE 7] 
(c) Retention of Ibuprofen.  Evidence for the role of the physicochemical properties of 
uncharged trace organic species in retention is also apparent in the nanofiltration of ibuprofen.  As 
the solution pH decreases to below its pKa value of 4.9, electrostatic repulsion between ibuprofen 
and the membrane surface is eliminated, allowing adsorption of the uncharged ibuprofen to the 
membrane.  While the elimination of charge repulsion reduces the removal rate, adsorption can 
contribute to the short-term removal of ibuprofen.  Both processes occur simultaneously and their 
relative contributions cannot be separated.  These processes are likely the cause for the decrease in 
the observed retention of ibuprofen by the NF-270 membrane as the pH decreases (Figure 6c).   
Because of adsorption to the membrane, ibuprofen concentration in the feed decreases when the 
pH is reduced to below 4.9 as demonstrated in Figure 8.  For runs with the tight NF-90 membrane, 
ibuprofen concentration in the permeate remains undetectable.  However, ibuprofen concentration 
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in the permeate increases noticeably following filtration by the loose NF-270 membrane.  Because 
the equivalent Stokes radius of ibuprofen calculated by the Wilke-Chang and the Stokes-Einstein 
equations (38) is 0.34 nm, smaller than the NF-270 membrane average pore size (0.42 nm), this 
indicates a possible convective transport of the ibuprofen through the pores of the NF-270.  This 
behavior is quite different from the adsorption of steroid hormones to the membrane, reported in our 
previous studies (22, 39), in which permeate concentration remained low for a long time because 
the adsorptive capacity of the membrane had not been reached.   
[FIGURE 8] 
Relative Role of Steric (Size) Exclusion.  When the solute-membrane interaction is purely 
steric, the observed retention of inert organics can be predicted by the pore transport model 
described in our previous publication (22).  In this modeling approach, the key input parameters are 
the membrane pore radius and the inert molecule size, as well as the convective permeate flux.  
Predictions of retention for the NF-270 and NF-90 membranes as a function of compound 
molecular weight along with the experimentally determined retention values of the three 
pharmaceuticals (taken at a pH where the compounds are uncharged) are presented in Figure 9.  
Note that the conditions used for modeling and for the pharmaceutical filtration experiments are 
identical.   
[FIGURE 9] 
Steric (size) exclusion is solely responsible for retention of uncharged and non-adsorptive 
organic solutes.  While electrostatic repulsion is absent, there is a relatively weak attraction between 
the molecule polar centers and fixed charge groups on the membrane surface.  For compounds with 
sufficiently high dipole moments, such permanent dipole – fixed charge interaction can direct the 
molecule to approach the membrane pores in a oriented fashion and the compound three-
dimensional structure becomes an important factor governing the separation process (37).  
Consequently, high dipole moment organics may exhibit lower retention than that expected based 
on a purely size exclusion mechanism, where the molecule approaches the membrane pore 
randomly and the Stokes radius is taken as an average representative size of the solute (Figure 9a).  
The influence of molecule polarity on retention is quite significant for compounds that are 
cylindrical in shape such as sulfamethoxazole (Figures 7 and 9a).  It must be emphasized that, even 
in this case, the interaction mechanism responsible for separation remains steric in nature.  Because 
the average pore radius of the NF-90 membrane is substantially smaller than the radii of the three 
pharmaceuticals used in this study, no polarity effects can be observed with this tight NF-90 
membrane and the retention is nearly complete (Figure 9b).   
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Table 1. Physicochemical Properties of Pharmaceuticals 
Pharmaceutical MW (g/mol) 
Stokes 
Radius 
(nm) 
Solubility 
in Water 
(mg/L) 
pKa Log Kow 
Dipole 
Moment 
(Debye) 
Sulfamethoxazole 253.3 0.38 a 600 b 
pKa1 = 1.7 c 
pKa2 = 5.6 c, 
5.7 b 
0.89 e 5.4 f 
Carbamazepine 236.3 0.37 a 17.7 c 2.3 e 2.45 e 3.6 f 
Ibuprofen 206.3 0.34 a 49 d 4.4 d - 4.9 e 3.5 e, 4.13 d 1.8 g 
a Calculated by the Wilke-Chang and the Stokes-Einstein equations (38). 
b
 Ref (40).  
c
 Ref (41).  
d
 Ref (34). 
e
 Ref (42).  
f
 estimated using HyperChem 7.0 (31).  
g
 Ref (43)  
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FIGURE CAPTIONS 
Figure 1: Chemical structure of the three pharmaceuticals used in this study.  Physicochemical 
properties of the compounds are described later in Table 1. 
 
Figure 2: Zeta potential of the NF-90 and NF-270 membranes as a function of pH in a background 
electrolyte solution containing 20 mM NaCl and 1 mM NaHCO3. 
 
Figure 3: Salt retention (measured by electric conductivity) by the NF-90 and NF-270 membranes 
as a function of pH.  Feed solution contained 20 mM NaCl and 1 mM NaHCO3. 
 
Figure 4: Speciation of sulfamethoxazole as a function of pH, calculated based on the pKa values in 
Table 1. 
 
Figure 5: Permeate and feed concentrations of sulfamethoxazole, ibuprofen, and carbamazepine as 
a function of filtration time for the NF-270 and NF-90 membranes.  The feed solution contained 
500 µg/L of the corresponding pharmaceutical in a background electrolyte solution containing 20 
mM NaCl and 1 mM NaHCO3.  Other experimental conditions were as follows: cross flow velocity 
= 30.4 cm/s, permeate flux = 15 µm/s (54 Lm−2h−1), pH = 8, and temperature = 20 oC.  The 
permeate and retentate were recirculated back to the feed reservoir during the nanofiltration run. 
 
Figure 6: Retention of (a) sulfamethoxazole (b) carbamazepine, and (c) ibuprofen by NF-90 and 
NF-270 membranes as a function of the solution pH.  The feed solution contained 500 µg/L of the 
corresponding pharmaceutical in a background electrolyte solution containing 20 mM NaCl and 1 
mM NaHCO3.  After each pH adjustment, the system was equilibrated for 1 hour prior to sample 
collection for analysis.  Other experimental conditions were as follows: cross-flow velocity = 30.4 
cm/s, permeate flux = 15 µm/s (54 Lm−2h−1), and temperature = 20 oC.  The permeate and retentate 
were recirculated back to the feed reservoir during the nanofiltration run. 
 
Figure 7: A three-Dimensional model of sulfamethoxazole and carbamazepine, simulated using 
HyperChem 7.0 (31).  
 
Figure 8: Feed and permeate concentration of ibuprofen as a function of the solution pH for the 
NF-90 membrane (top) and NF-270 membrane (bottom).  The feed solution contained 500 µg/L of 
ibuprofen in a background electrolyte solution containing 20 mM NaCl and 1 mM NaHCO3.  After 
each pH adjustment, the system was equilibrated for 1 hour prior to sample collection for analysis.  
Other experimental conditions were as follows: cross-flow velocity = 30.4 cm/s, permeate flux = 15 
µm/s (54 Lm−2h−1), and temperature = 20 oC.  The permeate and retentate were recirculated back to 
the feed reservoir during the nanofiltration run. 
  
Figure 9: The measured retention values of the three pharmaceuticals (open symbols)  
sulfamethoxazole (S), carbamazepine (C), and ibuprofen (I)  compared to model predictions 
(solid line), presented in our previous publication (22) for retention of non-adsorptive inert organics 
as a function of solute molecular weight: (a) NF-270 and (b) NF-90.  The retentions of these 
pharmaceuticals were measured at approx. pH 3.5, where the compounds they neutrally charged 
(Figure 6).  Parameters used in the pore transport model predictions were as follows: cross flow 
velocity = 30.4 cm/s, permeate flux = 15 µm/s (54 Lm−1h−1), and temperature = 20 oC. 
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BRIEF 
 
Retention mechanisms of pharmaceuticals by nanofiltration membranes are directly related to the 
molecule physicochemical characteristics, membrane pore size and charge, and solution chemistry. 
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